VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,284,523 | -33.9% | 605,907 | -3.7% | 0.00% | – |
| Q2 2023 | $1,944,494 | +607.1% | 629,286 | +1131.2% | 0.00% | – |
| Q1 2023 | $274,988 | -58.6% | 51,113 | -48.8% | 0.00% | – |
| Q4 2022 | $663,842 | +304.8% | 99,826 | +142.2% | 0.00% | – |
| Q3 2022 | $164,000 | -20.0% | 41,213 | 0.0% | 0.00% | – |
| Q2 2022 | $205,000 | -88.0% | 41,213 | -85.4% | 0.00% | – |
| Q1 2022 | $1,710,000 | -44.5% | 283,076 | +6.7% | 0.00% | – |
| Q4 2021 | $3,081,000 | -16.8% | 265,185 | +12.3% | 0.00% | – |
| Q3 2021 | $3,702,000 | -1.6% | 236,123 | +17.0% | 0.00% | – |
| Q2 2021 | $3,764,000 | -48.5% | 201,803 | +19.0% | 0.00% | – |
| Q1 2021 | $7,307,000 | – | 169,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |